Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
2 Feb 2015
Targeting Monocytes to Help Treat Autoimmune Disorders?
SUPPRESSION of the immune system in fighting diseases could be the fault of a population of white blood cells (WBCs), a group of studies led by…
2 Feb 2015
Monitoring ADMA Levels the Key to Avoiding Cardiovascular Disease?
FEARFUL side-effects that have prohibited the appearance of certain anti-inflammatory arthritis drugs in our pharmacies could soon become irrelevant…
27 Jan 2015
Editor’s Pick: Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?
Due to its increasing prevalence, exceeding 25% of the Western population, non-alcoholic fatty liver disease (NAFLD) merits recognition as one of the…
27 Jan 2015
Alcohol Dependence and Alcoholic Liver Disease
Summary of Presentations from the H. Lundbeck A/S-Supported Symposium, held at the 49th Annual International Liver Congress, London, United Kingdom…
27 Jan 2015
The Liver Meeting 2014: Summary of Presentations on Genotype 3 HCV Infection from the 65th Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Held in Boston, MA, USA, on 7th-11th November, 2014
After genotype 1 (GT1), genotype 3 (GT3) is the second most common hepatitis C virus (HCV) genotype worldwide, with an estimated worldwide prevalence of…
27 Jan 2015
Definitions of Acute-On-Chronic Liver Failure: The Past, the Present, and the Future
Acute-on-chronic liver failure (ACLF) is an entity used to define patients with liver cirrhosis presenting with acute decompensation.
27 Jan 2015
Hepatic-Based Inborn Errors of Metabolism
Inborn errors of metabolism (IEMs) are a vast, diverse, and heterogeneous set of genetic disorders. Hepatic-based IEMs are a significant cause of…
27 Jan 2015
Metabolic Syndrome in Paediatric Population: Is it Time to Think Back on Diagnosis Criteria?
Metabolic syndrome (MetS) represents an emerging disease in the paediatric population; it is characterised by a cluster of cardiometabolic abnormalities…
27 Jan 2015
Paediatric Metabolic Conditions of the Liver
Paediatric metabolic disorders with the most clinical manifestations of deranged hepatic metabolism are discussed. The conditions which will be stressed…
27 Jan 2015
Diagnosis and Management of Occult Hepatitis B Virus Infection: A Short Review
Occult hepatitis B virus infection (OBI) is a challenging clinical entity. It is defined as the presence of viral DNA in the liver or serum of subjects…
←
1
2
3
…
977
978
979
980
981
982
983
…
1,019
1,020
1,021
→